Itron, Inc. (NASDAQ:ITRI) Given Consensus Recommendation of “Hold” by Brokerages

Itron, Inc. (NASDAQ:ITRI) has been given an average recommendation of “Hold” by the thirteen ratings firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $131.3333.

Several analysts recently commented on the stock. Raymond James Financial initiated coverage on shares of Itron in a research report on Tuesday, April 21st. They issued an “underperform” rating for the company. Roth Capital reaffirmed a “buy” rating and issued a $136.00 target price on shares of Itron in a report on Wednesday, April 29th. TD Cowen decreased their target price on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Seaport Research Partners reissued a “buy” rating and set a $150.00 price target on shares of Itron in a report on Wednesday. Finally, Oppenheimer lifted their target price on Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th.

Itron Stock Down 3.4%

Shares of NASDAQ ITRI opened at $98.85 on Friday. The stock has a market cap of $4.33 billion, a PE ratio of 16.50, a price-to-earnings-growth ratio of 0.84 and a beta of 1.32. Itron has a 52-week low of $77.77 and a 52-week high of $142.00. The business has a 50-day moving average price of $84.38 and a 200 day moving average price of $89.82. The company has a quick ratio of 2.24, a current ratio of 2.75 and a debt-to-equity ratio of 0.96.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.29 by $0.30. The company had revenue of $562.90 million during the quarter, compared to analysts’ expectations of $566.34 million. Itron had a return on equity of 19.26% and a net margin of 11.90%.The firm’s revenue for the quarter was down 7.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.62 earnings per share. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Equities research analysts forecast that Itron will post 6.45 earnings per share for the current year.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Itron reported second-quarter adjusted earnings of $1.59 per share, well above the $1.29 analyst consensus. Strong margins, demand for its services and a solid backlog helped offset revenue of $562.9 million, which fell short of expectations. ITRI Q2 Earnings Top Despite Soft Revenues, Solid View Lifts Stock 26%
• Positive Sentiment: Management raised its fiscal 2026 earnings outlook to $6.30-$6.50 per share and projected third-quarter EPS of $1.50-$1.60. Investors viewed the improved profit outlook and margin performance as more important than the revenue shortfall, triggering a sharp post-earnings rally. Itron jumps after profit beat and upbeat outlook
• Positive Sentiment: Needham raised its price target from $116 to $128 and maintained a Buy rating, implying substantial potential upside from recent trading levels. The average analyst target indicates approximately 25% upside, although price-target estimates are not always reliable. Itron Raises Profit Outlook While Revenue Growth Remains Uneven
• Neutral Sentiment: Zacks highlighted Itron’s valuation, growth and momentum characteristics, while noting that analyst estimate revisions are a more useful signal than the consensus price target alone. Are Investors Undervaluing Itron Right Now?
• Negative Sentiment: Revenue declined 7.2% year over year, and the quarterly sales miss plus an initially softer third-quarter sales outlook raise concerns about uneven top-line growth. The recent pullback also appears consistent with profit-taking after the stock’s large post-earnings advance. Itron Missed Revenue and Still Jumped 26%

Insider Activity

In other news, SVP John F. Marcolini sold 322 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $27,167.14. Following the completion of the transaction, the senior vice president directly owned 24,689 shares of the company’s stock, valued at approximately $2,083,010.93. This represents a 1.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $26,914.03. Following the completion of the sale, the senior vice president directly owned 29,100 shares of the company’s stock, valued at $2,455,167. This represents a 1.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 3,946 shares of company stock valued at $324,420 over the last quarter. Corporate insiders own 1.77% of the company’s stock.

Institutional Investors Weigh In On Itron

Hedge funds and other institutional investors have recently bought and sold shares of the business. Employees Retirement System of Texas purchased a new position in shares of Itron in the 3rd quarter valued at about $32,000. Private Trust Co. NA boosted its holdings in Itron by 112.4% during the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after buying an additional 145 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after buying an additional 268 shares in the last quarter. Advisory Services Network LLC acquired a new position in Itron during the third quarter worth about $49,000. Finally, EverSource Wealth Advisors LLC increased its holdings in Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after buying an additional 81 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.